APA (7th ed.) Citation

J, T., F, L., P, B., U, O., KH, H., B, E., . . . T, B. (2025). Letter to the Editor Regarding "Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023". Advances in therapy, 42(8), 4096. https://doi.org/10.1007/s12325-025-03269-6

Chicago Style (17th ed.) Citation

J, Tomeczkowski, et al. "Letter to the Editor Regarding "Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023"." Advances in Therapy 42, no. 8 (2025): 4096. https://doi.org/10.1007/s12325-025-03269-6.

MLA (9th ed.) Citation

J, Tomeczkowski, et al. "Letter to the Editor Regarding "Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023"." Advances in Therapy, vol. 42, no. 8, 2025, p. 4096, https://doi.org/10.1007/s12325-025-03269-6.